AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2017
May 22, 2017
30870_dirs_2017-05-22_cd074ec7-c836-4b99-9df7-72fbcd467199.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-05-18
Reporting Person: Kaye Edward M. MD (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-05-18 | Non-Qualified Stock Option (right to buy) | $14.25 | A | 20000 | Acquired | 2027-05-18 | Common Stock (20000) | Direct |
Footnotes
F1: This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 18, 2018.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18